COLO B Stock Overview
Engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 1/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
Coloplast A/S Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr.818.20 |
| 52 Week High | kr.977.60 |
| 52 Week Low | kr.689.20 |
| Beta | 0.32 |
| 1 Month Change | -4.86% |
| 3 Month Change | -12.83% |
| 1 Year Change | -6.41% |
| 3 Year Change | -15.49% |
| 5 Year Change | 10.18% |
| Change since IPO | 6,303.31% |
Recent News & Updates
Coloplast's (CPH:COLO B) Solid Earnings May Rest On Weak Foundations
May 21
Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of DKK5.00
May 10Analyst Estimates: Here's What Brokers Think Of Coloplast A/S (CPH:COLO B) After Its Interim Report
May 09Recent updates
Coloplast's (CPH:COLO B) Solid Earnings May Rest On Weak Foundations
May 21Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of DKK5.00
May 10Analyst Estimates: Here's What Brokers Think Of Coloplast A/S (CPH:COLO B) After Its Interim Report
May 09A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)
Apr 26There's Reason For Concern Over Coloplast A/S' (CPH:COLO B) Price
Apr 08Is Coloplast (CPH:COLO B) A Risky Investment?
Mar 21Estimating The Intrinsic Value Of Coloplast A/S (CPH:COLO B)
Jan 09Coloplast A/S' (CPH:COLO B) Price Is Out Of Tune With Earnings
Dec 22These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well
Dec 04Coloplast (CPH:COLO B) Strong Profits May Be Masking Some Underlying Issues
Nov 16A Look At The Intrinsic Value Of Coloplast A/S (CPH:COLO B)
Sep 30Is Coloplast (CPH:COLO B) A Risky Investment?
Jun 28Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 18% Below Its Share Price
Jun 10Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly
Mar 22Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 25% Below Its Share Price
Mar 01These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well
Dec 14Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's
Nov 26Here's Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Looks Fair for the time being
Nov 25Coloplast's (CPH:COLO B) Shareholders Will Receive A Bigger Dividend Than Last Year
Nov 11With EPS Growth And More, Coloplast (CPH:COLO B) Makes An Interesting Case
Oct 25Estimating The Fair Value Of Coloplast A/S (CPH:COLO B)
Aug 26These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well
Jul 27Here's Why We Think Coloplast (CPH:COLO B) Is Well Worth Watching
Jul 12Is There An Opportunity With Coloplast A/S' (CPH:COLO B) 45% Undervaluation?
May 23Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of kr.5.00
May 08Coloplast (CPH:COLO B) Seems To Use Debt Rather Sparingly
Apr 13Here's Why I Think Coloplast (CPH:COLO B) Is An Interesting Stock
Mar 29Coloplast A/S (CPH:COLO B) Shares Could Be 41% Below Their Intrinsic Value Estimate
Feb 12Coloplast (CPH:COLO B) Could Easily Take On More Debt
Jan 12Is Now The Time To Put Coloplast (CPH:COLO B) On Your Watchlist?
Dec 28Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Is Not Excessive At All
Nov 25A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)
Oct 31Here's Why Coloplast (CPH:COLO B) Can Manage Its Debt Responsibly
Oct 02Do Coloplast's (CPH:COLO B) Earnings Warrant Your Attention?
Sep 16Does This Valuation Of Coloplast A/S (CPH:COLO B) Imply Investors Are Overpaying?
Aug 02Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly
Jul 01Does Coloplast (CPH:COLO B) Deserve A Spot On Your Watchlist?
Jun 16Shareholder Returns
| COLO B | DK Medical Equipment | DK Market | |
|---|---|---|---|
| 7D | -2.9% | -1.6% | 2.8% |
| 1Y | -6.4% | 1.2% | -23.1% |
Return vs Industry: COLO B underperformed the Danish Medical Equipment industry which returned -0.4% over the past year.
Return vs Market: COLO B underperformed the Danish Market which returned 33.7% over the past year.
Price Volatility
| COLO B volatility | |
|---|---|
| COLO B Average Weekly Movement | 3.4% |
| Medical Equipment Industry Average Movement | 5.6% |
| Market Average Movement | 4.3% |
| 10% most volatile stocks in DK Market | 9.6% |
| 10% least volatile stocks in DK Market | 2.9% |
Stable Share Price: COLO B has not had significant price volatility in the past 3 months.
Volatility Over Time: COLO B's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1954 | 15,930 | Kristian Villumsen | www.coloplast.com |
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand.
Coloplast A/S Fundamentals Summary
| COLO B fundamental statistics | |
|---|---|
| Market cap | kr.183.96b |
| Earnings (TTM) | kr.4.97b |
| Revenue (TTM) | kr.25.53b |
37.1x
P/E Ratio7.2x
P/S RatioIs COLO B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| COLO B income statement (TTM) | |
|---|---|
| Revenue | kr.25.53b |
| Cost of Revenue | kr.8.39b |
| Gross Profit | kr.17.14b |
| Other Expenses | kr.12.17b |
| Earnings | kr.4.97b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 20, 2024
| Earnings per share (EPS) | 22.08 |
| Gross Margin | 67.13% |
| Net Profit Margin | 19.45% |
| Debt/Equity Ratio | 144.9% |
How did COLO B perform over the long term?
See historical performance and comparison